{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:53:38Z","timestamp":1792857218826,"version":"4.5.0"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.ejmech.2019.03.009","type":"journal-article","created":{"date-parts":[[2019,3,7]],"date-time":"2019-03-07T21:22:11Z","timestamp":1551993731000},"page":"185-199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":162,"special_numbering":"C","title":["Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review"],"prefix":"10.1016","volume":"169","author":[{"given":"Biswanath","family":"Dinda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manikarna","family":"Dinda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goutam","family":"Kulsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankita","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhajit","family":"Dinda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.03.009_bib1","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1586\/14737159.2013.850033","article-title":"Molecular biomarkers of neurodegeneration","volume":"13","author":"Hoglund","year":"2013","journal-title":"Expert Rev. Mol. Daign."},{"key":"10.1016\/j.ejmech.2019.03.009_bib2","doi-asserted-by":"crossref","first-page":"6435861","DOI":"10.1155\/2018\/6435861","article-title":"Oxidant\/antioxidant imbalance in Alzheimer's disease: therapeutic and diagnostic prospects","author":"Wojsiat","year":"2018","journal-title":"Oxid. Med. Cell. Long."},{"key":"10.1016\/j.ejmech.2019.03.009_bib3","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.2174\/092986710791859324","article-title":"New therapeutic strategy for Parkinson's and Alzheimer's disease","volume":"17","author":"Esposito","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.03.009_bib4","series-title":"Cyclopentanoid Terpene Derivatives","first-page":"1","author":"Bobbitt","year":"1969"},{"key":"10.1016\/j.ejmech.2019.03.009_bib5","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1248\/cpb.55.689","article-title":"Naturally occurring secoiridoids and bioactivity of naturally occurring iridoids and secoiridoids. a review, part 2","volume":"55","author":"Dinda","year":"2007","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2019.03.009_bib6","series-title":"Natural Products: Phytochemistry,botany,and Metabolism of Alkaloids, Phenolics and Terpenes","first-page":"3009","article-title":"Iridoids","author":"Dinda","year":"2013"},{"key":"10.1016\/j.ejmech.2019.03.009_bib7","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.2174\/1568026616666160204122449","article-title":"Neuroprotective role of natural polyphenols","volume":"16","author":"Spagnuolo","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.03.009_bib8","first-page":"589","article-title":"Effect of radix Rehmanniae preparata on the expression of c-fos and NGF in hippocampi and learning and memory in rats with damaged thalamic arcuate nucleus","volume":"27","author":"Cui","year":"2004","journal-title":"Zhong Yao Cai"},{"key":"10.1016\/j.ejmech.2019.03.009_bib9","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1248\/bpb.33.1841","article-title":"Geniposide induces the expression of heme oxygenase-1 via PI3K\/Nrf2-signaling to enhance the antioxidant capacity in primary hippocampal neurons","volume":"33","author":"Yin","year":"2010","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2019.03.009_bib10","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jalz.2018.02.001","article-title":"Alzheimer's disease facts and figures","volume":"14","author":"Alzheimer\u2019s Association","year":"2018","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.ejmech.2019.03.009_bib11","first-page":"146","article-title":"Uber eine eigenartige Erkrankung der Hirnrinde","volume":"109","author":"Alzheimer","year":"1907","journal-title":"Allg. Zeitschr. Pyschiatr-Gerichtl. Med."},{"key":"10.1016\/j.ejmech.2019.03.009_bib12","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1001\/archpsyc.1981.01780350019001","article-title":"Dementia of the Alzheimer type.Clinical genetics, natural history, and associated conditions","volume":"38","author":"Heston","year":"1981","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.ejmech.2019.03.009_bib13","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.2165\/11595870-000000000-00000","article-title":"Current and emerging drug treatment options for Alzheimer's disease: a systematic review","volume":"71","author":"Herrmann","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2019.03.009_bib14","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cell.2005.02.008","article-title":"Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective","volume":"120","author":"Tanzi","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2019.03.009_bib15","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1096\/fj.10-175158","article-title":"A\u00a0small- molecule enhancer of autophagy decreases levels of A\u03b2 and APP-CTF via Atg5-dependent autophagy pathway","volume":"25","author":"Tian","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.ejmech.2019.03.009_bib16","first-page":"117","article-title":"Advances in RNA interferences in Alzheimer's disease research","volume":"7","author":"Chen","year":"2013","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmech.2019.03.009_bib17","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1523\/JNEUROSCI.3993-06.2007","article-title":"Apolipoprotein receptor and XII\/\u03b2 mediate apolipoprotein E-induced endocytosis of amyloid \u03b2 precursor protein and \u03b2-secretase, leading to amyloid-\u03b2 production","volume":"27","author":"He","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ejmech.2019.03.009_bib18","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI10498","article-title":"Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL-receptor-related protein-1 at the blood-brain barrier","volume":"106","author":"Shibata","year":"2000","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.ejmech.2019.03.009_bib19","doi-asserted-by":"crossref","first-page":"7538","DOI":"10.1523\/JNEUROSCI.0260-15.2015","article-title":"ApoE 4 and A beta oligomers reduce BDNF expression via HDAC nuclear translocation","volume":"35","author":"Sen","year":"2015","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ejmech.2019.03.009_bib20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pnpbp.2013.12.001","article-title":"GSK-3\u03b2, CREB, and BDNF in peripheral blood of patients with Alzheimer's disease and depression","volume":"50","author":"Platenik","year":"2014","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejmech.2019.03.009_bib21","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/cns.12312","article-title":"Lenti-GDNF gene therapy protects against Alzheimer's disease-like neuropathology in 3\u00d7 Tg-AD mice and MC65 cells","volume":"20","author":"Revilla","year":"2014","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ejmech.2019.03.009_bib22","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3233\/JAD-2004-6610","article-title":"Induction of hyperphosphorylated tau in primary rat cortical neuron cultures mediated by oxidative stress and glycogen synthase kinase-3","volume":"6","author":"Lovell","year":"2004","journal-title":"J.\u00a0Alzheimer's Dis."},{"key":"10.1016\/j.ejmech.2019.03.009_bib23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0306-4522(00)00200-1","article-title":"Insulin-like growth factor-1 and insulin mediate transient site-selective increases in tau phosphorylation in primary cortical neurons","volume":"99","author":"Lesort","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejmech.2019.03.009_bib24","doi-asserted-by":"crossref","first-page":"19547","DOI":"10.1074\/jbc.272.31.19547","article-title":"Insulin and insulin-like growth factor-1 regulate tau phophorylation in cultured human neurons","volume":"272","author":"Hong","year":"1997","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.03.009_bib25","first-page":"374","article-title":"Calcium dysregulation in Alzheimer's disease: a target for new drug development","volume":"7","author":"Wang","year":"2017","journal-title":"J.\u00a0Alzheimer\u2019s Dis. Park."},{"key":"10.1016\/j.ejmech.2019.03.009_bib26","doi-asserted-by":"crossref","first-page":"9145","DOI":"10.1074\/jbc.M112.427880","article-title":"Caspase inhibitors protect neurons by enabling selective necroptosis in inflamed microglia","volume":"288","author":"Fricker","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.03.009_bib27","first-page":"108","article-title":"Caspases as therapeutic targets in Alzheimer's disease: is it time to \u2018 cut\u2019 to the chase ?","volume":"2","author":"Rohn","year":"2009","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.ejmech.2019.03.009_bib28","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nm0798-827","article-title":"Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity","volume":"4","author":"Geula","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2019.03.009_bib29","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1083\/jcb.200110119","article-title":"Selective cytotoxicity of intracellular amyloid beta peptide 1-42 through p53 and Bax in cultured primary human neurons","volume":"156","author":"Zhang","year":"2002","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.ejmech.2019.03.009_bib30","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006320","article-title":"Animal models of Alzheimer's disease","volume":"2","author":"LaFerla","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ejmech.2019.03.009_bib31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0896-6273(03)00810-9","article-title":"BACE-1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease","volume":"41","author":"Ohno","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.ejmech.2019.03.009_bib32","first-page":"10","article-title":"Comparison of catalpol in Rehmannia glutinosa Libosch of different producing areas, Trad","volume":"14","author":"Liu","year":"2001","journal-title":"Chin. Med. Res."},{"key":"10.1016\/j.ejmech.2019.03.009_bib33","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.brainres.2006.09.058","article-title":"Catalpol increases hippocampal neuroplasticity and up-regulates PKC and BDNF in the aged rats","volume":"1123","author":"Liu","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.ejmech.2019.03.009_bib34","doi-asserted-by":"crossref","first-page":"495","DOI":"10.4236\/jbbs.2012.24058","article-title":"Catalpol upregulates hippocampal GAP-43 level of aged rats with enhanced spatial memory and behaviour response","volume":"2","author":"Liu","year":"2012","journal-title":"J.\u00a0Behav. Brain Sci."},{"key":"10.1016\/j.ejmech.2019.03.009_bib35","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3892\/mmr.2015.4496","article-title":"Catalpol preserves neural function and attenuates the pathology of Alzheimer's disease in mice","volume":"13","author":"Huang","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejmech.2019.03.009_bib36","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.neulet.2008.07.029","article-title":"Protective effects of catalpol against H2O2-induced oxidative stress in astrocytes primary cultures","volume":"442","author":"Bi","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejmech.2019.03.009_bib37","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3389\/fnagi.2018.00066","article-title":"Catalpol inhibits amyloid-\u03b2 generation through promoting \u03b1-cleavage of APP in Swedish mutant APP overexpressed N2a cells","volume":"10","author":"Wang","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ejmech.2019.03.009_bib38","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.2174\/1871527311211080015","article-title":"Geniposide regulates insulin-degrading enzyme expression to inhibit the cytotoxicity of A\u03b21-42 in cortical neurons","volume":"11","author":"Yin","year":"2012","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"key":"10.1016\/j.ejmech.2019.03.009_bib39","article-title":"GLP-1 receptor regulates cell growth through regulating IDE expression level in A\u03b21-42 treated PC-12 cells, Biosci","volume":"38","author":"Li","year":"2018","journal-title":"For. Rep."},{"key":"10.1016\/j.ejmech.2019.03.009_bib40","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1515\/revneuro-2015-0005","article-title":"Neuroprotective effects of geniposide on Alzheimer's disease pathology","volume":"26","author":"Liu","year":"2015","journal-title":"Rev. Neurosci."},{"issue":"6\u20137","key":"10.1016\/j.ejmech.2019.03.009_bib41","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.neuint.2007.04.021","article-title":"Geniposide, a novel agonist for GLP-1 receptor, prevents PC-12 cells from oxidative damage via MAP kinase pathway","volume":"51","author":"Liu","year":"2007","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejmech.2019.03.009_bib42","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/bpa.12116","article-title":"Geniposide ameliorates learning memory deficits, reduces tau phosphorylation and decreases apoptosis via GSK-3\u03b2 pathway in streptozotocin-induced Alzheimer rat model","volume":"24","author":"Gao","year":"2014","journal-title":"Brain Pathol."},{"key":"10.1016\/j.ejmech.2019.03.009_bib43","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/1097-4547(20001101)62:3<463::AID-JNR16>3.0.CO;2-7","article-title":"Phosphorylation of human tau protein by microtubule-associated kinases; GSK-3\u03b2 and cdk-5 are key participants","volume":"62","author":"Flaherty","year":"2000","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.ejmech.2019.03.009_bib44","doi-asserted-by":"crossref","first-page":"580","DOI":"10.2174\/1567205011666140618095925","article-title":"Geniposide attenuates mitochondrial dysfunction and memory deficits in APP\/PS1 transgenic mice","volume":"11","author":"Lv","year":"2014","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.ejmech.2019.03.009_bib45","first-page":"309","article-title":"Geniposide alleviates amyloid-induced synaptic injury by protecting axonal mitochondrial trafficking","volume":"10","author":"Zhang","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejmech.2019.03.009_bib46","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neuropharm.2014.09.019","article-title":"Multi-faced neuroprotective effects of geniposide depending on the RAGE- mediated signalling in Alzheimer mouse model","volume":"89","author":"Lv","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2019.03.009_bib47","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s12272-016-0875-9","article-title":"Geniposide attenuates the level of A\u03b21-42 via enhancing leptin signalling in cellular and APP\/PS1 transgenic mice","volume":"40","author":"Liu","year":"2017","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.ejmech.2019.03.009_bib48","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.bbadis.2008.12.004","article-title":"Leptin signalling in brain: a link between nutrition and cognition?","volume":"1792","author":"Morrison","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2019.03.009_bib49","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.neuroscience.2015.06.042","article-title":"Harpagoside ameliorates the amyloid-\u03b2-induced cognitive impairment in rats via up-regulating BDNF expression and MAPK\/PI3K pathways","volume":"303","author":"Li","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejmech.2019.03.009_bib50","first-page":"445","article-title":"Harpagoside rescues the memory impairments in chronic cerebral hyperfusion rats by inhibiting PTEN activity","volume":"63","author":"Zhang","year":"2018","journal-title":"J.\u00a0Alzheimer's Dis."},{"key":"10.1016\/j.ejmech.2019.03.009_bib51","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1080\/14786419.2012.718774","article-title":"\u03b2-Secretase (BACE1) inhibitory property of loganin isolated from Corni fructus","volume":"27","author":"Youn","year":"2013","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.ejmech.2019.03.009_bib52","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.neuint.2011.02.010","article-title":"Oleuropein and derivatives from olives as Tau aggregation inhibitors","volume":"58","author":"Daccache","year":"2011","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejmech.2019.03.009_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071702","article-title":"The polyphenol oleuropein aglycone protects TgCRND8 mice against A\u03b2 plaque pathology","volume":"8","author":"Grossi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2019.03.009_bib54","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3233\/JAD-142850","article-title":"Oleuropein aglycone: a possible drug against degenerative conditions. In\u00a0vivo evidence of its effectiveness against Alzheimer's disease","volume":"45","author":"Casamenti","year":"2015","journal-title":"J.\u00a0Alzheimer's Dis."},{"key":"10.1016\/j.ejmech.2019.03.009_bib55","doi-asserted-by":"crossref","first-page":"35344","DOI":"10.18632\/oncotarget.6119","article-title":"Oleuropein aglycone induces autophagy via the AMPK\/mTOR signalling pathway: a mechanistic insight","volume":"6","author":"Rigacci","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2019.03.009_bib56","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.neurobiolaging.2014.08.029","article-title":"Oleuropein aglycone protects against pyroglutamylated-3-amyloid-\u03b2- toxicity: biochemical and functional correlates","volume":"36","author":"Luccarini","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ejmech.2019.03.009_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058893","article-title":"Oleuropein aglycone protects transgenic C.\u00a0elegans strains expressing A\u03b242 by reducing plaque load and motor deficit","volume":"8","author":"Diomede","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2019.03.009_bib58","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10571-012-9880-9","article-title":"Oleuropein, an anti-oxidant polyphenol constituent of olive promotes \u03b1-secretase cleavage of the amyloid precursor protein (A\u03b2PP)","volume":"33","author":"Kostomoiri","year":"2013","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.ejmech.2019.03.009_bib59","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1111\/j.1471-4159.2009.06224.x","article-title":"Inhibition of tau fibrillization by oleocanthal via reaction with the amino group of tau","volume":"110","author":"Li","year":"2009","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.ejmech.2019.03.009_bib60","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1021\/cn400024q","article-title":"Olive-oil-derived oleocanthal enhances \u03b2-amylod clearance as a potential neuroprotective mechanism against Alzheimer's disease: in\u00a0vitro and in\u00a0vivo studies","volume":"4","author":"Abuznait","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2019.03.009_bib61","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1021\/acschemneuro.5b00190","article-title":"Oleocanthal enhances amyloid- \u03b2 clearance from the brains of TgSwDI mice and in\u00a0vitro across a human blood-brain barrier model","volume":"6","author":"Qosa","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2019.03.009_bib62","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.neuroscience.2017.03.059","article-title":"Oleocanthal ameliorates amyloid-\u03b2 oligomers toxicity on astrocytes and neuronal cells: in\u00a0vitro studies","volume":"352","author":"Batarseh","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejmech.2019.03.009_bib63","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1176\/jnp.14.2.223","article-title":"An essay on the shaking Palsy 1817","volume":"14","author":"Parkinson","year":"2002","journal-title":"J.\u00a0Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.ejmech.2019.03.009_bib64","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.ejmech.2019.03.009_bib65","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1111\/j.1460-9568.2005.04285.x","article-title":"Modulation of motor function by stress: a novel concept of the effects of stress and corticosterone on behaviour","volume":"22","author":"Metz","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejmech.2019.03.009_bib66","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s10495-008-0309-3","article-title":"Cell death pathways of Parkinson's disease: proximal triggers, distal effectors, and final steps","volume":"14","author":"Levy","year":"2009","journal-title":"Apoptosis"},{"key":"10.1016\/j.ejmech.2019.03.009_bib67","doi-asserted-by":"crossref","first-page":"a008888","DOI":"10.1101\/cshperspect.a008888","article-title":"Genetics of Parkinson's disease","volume":"2","author":"Klein","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ejmech.2019.03.009_bib68","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2147\/NDT.S2006","article-title":"Current approaches to the treatment of Parkinson's disease","volume":"4","author":"Jaankovic","year":"2008","journal-title":"Neurosychiatr. Dis. Treat."},{"issue":"Suppl","key":"10.1016\/j.ejmech.2019.03.009_bib69","first-page":"S99","article-title":"Blood-based biomarkers of Parkinson's disease, proceedings of XX World congress on parkinsonism & related","volume":"20","author":"Chahine","year":"2014","journal-title":"Disorders"},{"issue":"Pt 3","key":"10.1016\/j.ejmech.2019.03.009_bib70","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/brain\/awq008","article-title":"DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease","volume":"133","author":"Hong","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.ejmech.2019.03.009_bib71","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/j.metabol.2014.10.030","article-title":"Biomarker of Parkinson's disease: present and future","volume":"64","author":"Miller","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.ejmech.2019.03.009_bib72","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/aje\/kwr362","article-title":"Use of calcium channel blockers and Parkinson's disease","volume":"175","author":"Pasternak","year":"2012","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ejmech.2019.03.009_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186508","article-title":"Serum IGF-1 is associated with cognitive functions in early, drug na\u00efve Parkinson's disease","volume":"12","author":"Picillo","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2019.03.009_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2015.09.035","article-title":"A\u00a0novel dual GLP-1 and GLP receptor agonist is neuroprotective in the MPTP mouse model of Parkinson's disease by increasing the expression of BDNF","volume":"1634","author":"Ji","year":"2016","journal-title":"Brain Res."},{"key":"10.1016\/j.ejmech.2019.03.009_bib75","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0079-6123(10)83009-2","article-title":"Assemblies of glutamate receptor subunits with post-synaptic density proteins and their alternations in Parkinson's disease","volume":"183","author":"Gardoni","year":"2010","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.ejmech.2019.03.009_bib76","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1476-5381.2011.01426.x","article-title":"Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease","volume":"164","author":"Duty","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.03.009_bib77","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of Parkinson's disease","volume":"2","author":"Jackson-Lewis","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejmech.2019.03.009_bib78","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/1096-9861(20001120)427:3<440::AID-CNE10>3.0.CO;2-7","article-title":"Time course of degenerative alternations in nigral dopaminergic neurons following a 6-hydroxydopamine lesion","volume":"427","author":"Zuch","year":"2000","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.ejmech.2019.03.009_bib79","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0166-4328(02)00180-8","article-title":"Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats","volume":"136","author":"Alam","year":"2002","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejmech.2019.03.009_bib80","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1359-6446(05)03693-7","article-title":"Drosophila models pioneer a new approach to drug discovery for Parkinson's disease","volume":"11","author":"Whiteworth","year":"2006","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2019.03.009_bib81","doi-asserted-by":"crossref","first-page":"15022","DOI":"10.1038\/npjparkd.2015.22","article-title":"Delaying aging is neuroprotective in Parkinson's disease: a genetic analysis in C.\u00a0elegans models","volume":"1","author":"Cooper","year":"2015","journal-title":"npj Parkinson\u2019s Disease"},{"key":"10.1016\/j.ejmech.2019.03.009_bib82","doi-asserted-by":"crossref","first-page":"e984","DOI":"10.1038\/cddis.2013.513","article-title":"Mitochondrial dysfunction, oxidative stress, and neurodegeneration elicited by a bacterial metabolite in a C.\u00a0elegans Parkinson's model","volume":"5","author":"Ray","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2019.03.009_bib83","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.lfs.2006.09.010","article-title":"Catalpol protects dopaminergic neurons from LPS-induced neurotoxicity in mesencephalic neuron-glia cultures","volume":"80","author":"Tian","year":"2006","journal-title":"Life Sci."},{"issue":"Suppl","key":"10.1016\/j.ejmech.2019.03.009_bib84","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/j.jbiotec.2008.07.183","article-title":"Catalpol protects mesencephalic neurons against MPTP-induced neurotoxicity via attenuation of mitochondrial dysfunction and MAO-B activity","volume":"136","author":"Bi","year":"2008","journal-title":"J.\u00a0Biotechnol."},{"key":"10.1016\/j.ejmech.2019.03.009_bib85","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.tiv.2008.09.007","article-title":"Catalpol protects mesencephalic neurons against MPTP-induced neurotoxicity via attenuation of mitochondrial dysfunction and MAO-B activity","volume":"22","author":"Bi","year":"2008","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.ejmech.2019.03.009_bib86","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.etap.2006.11.012","article-title":"Efficacy of catalpol as protectant against oxidative stress and mitochondrial dysfunction on rotenone-induced toxicity in mice brain","volume":"23","author":"Mao","year":"2007","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.03.009_bib87","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.neuroscience.2010.01.048","article-title":"Catalpol attenuates MPTP-induced neuronal degeneration of nigral-striatal dopaminergic pathway in mice through elevating glial cell derived neurotrophic factor in striatum","volume":"167","author":"Xu","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejmech.2019.03.009_bib88","first-page":"524878","article-title":"Catalpol modulates lifespan via DAF\/FOXO and SKN 1\/Nrf 2 activation in Caenorhabditis elegans, Evid. Based Complement","author":"Seo","year":"2015","journal-title":"Altern. Med."},{"key":"10.1016\/j.ejmech.2019.03.009_bib89","doi-asserted-by":"crossref","first-page":"984","DOI":"10.2174\/1871527311211080007","article-title":"Iridoid compound 10-O-trans-p-coumaroylcatalpol extends longevity and reduces alpha synuclein aggregation in Caenorhabditis elegans","volume":"11","author":"Shukla","year":"2012","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"key":"10.1016\/j.ejmech.2019.03.009_bib90","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejphar.2015.09.029","article-title":"Neuroprotective effects of geniposide in the MPTP mouse model of Parkinson's disease","volume":"768","author":"Chen","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.03.009_bib91","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.4103\/1673-5374.167760","article-title":"Geniposide prevents rotenone-induced apoptosis in primary cultured neurons","volume":"10","author":"Li","year":"2015","journal-title":"Neural. Regen. Res."},{"key":"10.1016\/j.ejmech.2019.03.009_bib92","first-page":"1945","article-title":"MicroRNAs in Parkinson's disease and emerging therapeutic targets, Neural","volume":"12","author":"Martinez","year":"2017","journal-title":"Regen. Res."},{"key":"10.1016\/j.ejmech.2019.03.009_bib93","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.brainres.2016.05.011","article-title":"Geniposide reduces \u03b1-synuclein by blocking microRNA-21\/lysosome-associated membrane protein 2A interaction in Parkinson disease models","volume":"1644","author":"Su","year":"2016","journal-title":"Brain Res."},{"key":"10.1016\/j.ejmech.2019.03.009_bib94","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/j.1471-4159.2011.07635.x","article-title":"Harpagoside attenuates MPTP\/MPP+-induced dopaminergic neurodegeneration and movement disorder via elevating glial cell line-derived neurotrophic factor","volume":"120","author":"Sun","year":"2012","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.ejmech.2019.03.009_bib95","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/biof.1171","article-title":"Beneficial properties of natural phenols: highlight on protection against pathological conditions associated with amyloid aggregation","volume":"40","author":"Stefani","year":"2014","journal-title":"Biofactors"},{"key":"10.1016\/j.ejmech.2019.03.009_bib96","doi-asserted-by":"crossref","first-page":"14127","DOI":"10.3390\/ijms131114127","article-title":"Bioavailability and brain-targeting of geniposide in Gardenia-borneol compound by different administration routes in mice","volume":"13","author":"Lu","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2019.03.009_bib97","doi-asserted-by":"crossref","first-page":"8088","DOI":"10.1021\/jf0709698","article-title":"Encapsulation of olive leaf extract in beta-cyclodextrin","volume":"55","author":"Mourtzinos","year":"2007","journal-title":"J.\u00a0Agric. Food Chem."},{"key":"10.1016\/j.ejmech.2019.03.009_bib98","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.neures.2006.07.006","article-title":"Functional characterization of the brain-to-blood efflux clearance of human amyloid-beta peptide (1-40) across the rat blood brain barrier","volume":"56","author":"Ito","year":"2006","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.ejmech.2019.03.009_bib99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj0960001","article-title":"Catalpol and methylcatalpol: naturally occurring glycosides in Plantago and Buddleia species","volume":"96","author":"Duff","year":"1965","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2019.03.009_bib100","first-page":"209","article-title":"Analysis of aucubin and catalpol content in different plant parts of four Globularia species","volume":"88","author":"Sertic","year":"2015","journal-title":"J.\u00a0Appl. Bot. Food Qual."},{"key":"10.1016\/j.ejmech.2019.03.009_bib101","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1515\/znc-2004-1-206","article-title":"Determination of aucubin and catalpol in Plantago species by micellar electrokinetic chromatography","volume":"59c","author":"Jurisic","year":"2004","journal-title":"Z.\u00a0Naturforsch."},{"key":"10.1016\/j.ejmech.2019.03.009_bib102","first-page":"4956589","article-title":"Simultaneous determination of catalpol, aucubin and geniposidic acid in different development stages of Rehmannia glutinosa leaves by high performance liquid chromatography","volume":"2016","author":"Wang","year":"2016","journal-title":"J.\u00a0Anal. Methods Chem."},{"key":"10.1016\/j.ejmech.2019.03.009_bib103","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0021-9673(99)01170-X","article-title":"Extraction of iridoid glycosides and their determination by micellar electrokinetic capillary chromatography","volume":"868","author":"Soumi","year":"2000","journal-title":"J.\u00a0Chromatogr. A"},{"key":"10.1016\/j.ejmech.2019.03.009_bib104","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0031-9422(97)80017-9","article-title":"10-O-Acylated iridoid glucosides from leaves of Premna subscandens","volume":"46","author":"Sudo","year":"1997","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ejmech.2019.03.009_bib105","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.chroma.2005.09.026","article-title":"Large-scale isolation and purification of geniposide from the fruit of Gardenia jasminoides Ellis by high-speed counter-current chromatography","volume":"1100","author":"Zhou","year":"2005","journal-title":"J.\u00a0Chromatogr. A"},{"key":"10.1016\/j.ejmech.2019.03.009_bib106","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1248\/cpb.53.1342","article-title":"Iridoid glucosides from the fruit of Genipa americana","volume":"53","author":"Ono","year":"2005","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2019.03.009_bib107","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0031-9422(02)00096-1","article-title":"Iridoid glucosides from the roots of Vietnamese Paederia scandens","volume":"60","author":"Quang","year":"2002","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ejmech.2019.03.009_bib108","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0031-9422(03)00109-2","article-title":"Iridoid glucosides from Randia spinosa","volume":"63","author":"Hamerski","year":"2003","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ejmech.2019.03.009_bib109","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.phytochem.2013.04.009","article-title":"Harpagoside: from Kalahari desert to pharmacy shelf","volume":"92","author":"Georgiev","year":"2013","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ejmech.2019.03.009_bib110","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/pca.938","article-title":"Preparative isolation and purification of harpagoside from Scrophulasia mingpoensis Hemsley by high-speed counter-current chromatography","volume":"17","author":"Tong","year":"2006","journal-title":"Phytochem. Anal."},{"key":"10.1016\/j.ejmech.2019.03.009_bib111","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.phymed.2011.08.064","article-title":"Effect of loganin on experimental diabetic nephropathy","volume":"19","author":"Jiang","year":"2012","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2019.03.009_bib112","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jep.2016.09.042","article-title":"Cornus mas L., an important European and Asian traditional food and medicine: ethnomedicine, phytochemistry and pharmacology for its commercial utilization in drug industry","volume":"193","author":"Dinda","year":"2016","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2019.03.009_bib113","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1007\/s00044-011-9832-9","article-title":"A\u00a0cytotoxic agent from Strychnos nux-vomica and biological evaluation of its modified analogues","volume":"21","author":"Khan","year":"2012","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2019.03.009_bib114","doi-asserted-by":"crossref","first-page":"9129","DOI":"10.1021\/jf101847e","article-title":"Separation and identification of phenolic compounds of extra-virgin olive oil from Olea europaea L. By HPLC-DAD-SPE-NMR\/MS. Identification of a new diastereoisomer of the aldehydic form of oleuropein aglycone","volume":"58","author":"Perez-Trujillo","year":"2010","journal-title":"J.\u00a0Agric. Food Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352341930220X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352341930220X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:50:05Z","timestamp":1759326605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352341930220X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":114,"alternative-id":["S022352341930220X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.03.009","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}